| Phase 21 trial |
|
Phase 2
|
NCT02083276 |
Mar 2014 → Apr 2015 |
chlamydia trachomatis infectious disease |
Oslo University Hospital |
Terminated
|
No outcome recorded
|
| Phase 32 trials |
|
Phase 3
|
NCT05224401 |
May 2023 → Sep 2027 expected |
bacterial urinary tract infection |
Lund University |
Recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT05545137 |
Sep 2022 → Feb 2024 |
urinary tract infection |
Benova (Tianjin) Innovative medicine Research Co., Ltd. |
Completed
|
No outcome recorded
|
| Phase 44 trials · 1 missed |
|
Phase 4
|
NCT07236944 |
Dec 2025 → Mar 2029 expected |
bacterial urinary tract infection |
Uppsala University |
Recruiting
|
No outcome recorded
|
|
Phase 4
|
NCT06709196 |
Jan 2025 → Jan 2027 expected |
urinary bladder cancer |
Rigshospitalet, Denmark |
Recruiting
|
No outcome recorded
|
|
Phase 4
|
NCT03228108 |
Apr 2018 → Sep 2021 |
infectious disease, prostate cancer |
Radboud University Medical Center |
Completed
|
Missed primary
|
|
Phase 4
|
NCT03282006 |
Sep 2017 → Apr 2020 |
pyelonephritis |
Sykehuset i Vestfold HF |
Completed
|
No outcome recorded
|
| Comparator or background therapy2 trials |
|
Phase 2
|
NCT07407673 Comparator |
Jan 2027 → Jul 2029 expected |
bacterial infectious disease, disease related to solid organ transplantation |
Susanne Dam Nielsen, MD, DMSc |
Not yet recruiting
|
No outcome recorded
|
|
Phase 4
|
NCT04959331 Comparator |
Nov 2021 → Dec 2024 |
urinary tract infection |
Jordi Gol Institute for Primary Care Research |
Completed
|
No outcome recorded
|